Theriva Biologics, Inc. (TOVX) is a clinical-stage biotherapeutics company. Based on the limited excerpt provided from their 10-K filing, the company operates in the biologics space. Insufficient detail is available in the provided text to describe specific products, services, or therapeutic focus areas beyond the company name and ticker symbol.
Q2 FY2026 — expected 2026-09-07
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0001104659-26-026767 | EDGAR | 102K words |
| 2025-03-06 | 2024-12-31 | 0001410578-25-000285 | EDGAR | — |
| 2024-03-25 | 2023-12-31 | 0001410578-24-000293 | EDGAR | — |
| 2023-03-30 | 2022-12-31 | 0001410578-23-000428 | EDGAR | — |
| 2022-03-16 | 2021-12-31 | 0001410578-22-000405 | EDGAR | — |
| 2021-03-04 | 2020-12-31 | 0001104659-21-032150 | EDGAR | — |
| 2020-02-20 | 2019-12-31 | 0001104659-20-023415 | EDGAR | — |
| 2019-02-27 | 2018-12-31 | 0001144204-19-010592 | EDGAR | — |
| 2018-02-22 | 2017-12-31 | 0001144204-18-010286 | EDGAR | — |
| 2017-03-02 | 2016-12-31 | 0001144204-17-012545 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-11 | 2026-06-30 | 0001104659-26-093786 | EDGAR | — |
| 2025-11-12 | 2025-09-30 | 0001104659-25-109828 | EDGAR | 37K words |
| 2025-08-11 | 2025-06-30 | 0001410578-25-001654 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001410578-25-001242 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001410578-24-001850 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001410578-24-001342 | EDGAR | — |
| 2024-05-07 | 2024-03-31 | 0001410578-24-000601 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001410578-23-002348 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0001410578-23-001584 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001410578-23-000987 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001410578-22-003167 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001410578-22-002238 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-11 | 0001104659-26-093782 | EDGAR | — |
| 2026-08-06 | 0001104659-26-091674 | EDGAR | — |
| 2026-08-04 | 0001104659-26-090064 | EDGAR | — |
| 2026-03-23 | 0001104659-26-033051 | EDGAR | 1K words |
| 2026-03-12 | 0001104659-26-026765 | EDGAR | — |
| 2026-02-18 | 0001104659-26-016792 | EDGAR | — |
| 2026-02-12 | 0001104659-26-013907 | EDGAR | — |
| 2026-01-12 | 0001104659-26-002750 | EDGAR | — |
| 2025-12-29 | 0001104659-25-124523 | EDGAR | — |
| 2025-12-15 | 0001104659-25-121246 | EDGAR | — |
554 total filings indexed. 522 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000894158 |
| Ticker | TOVX |
| Exchange | NYSE |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NV |
| Website | https://www.therivabio.com |
| Listed | 1993-04-05 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/TOVX (~200 tokens, structured JSON with cryptographic provenance)